Why are Recombinant Clotting Factors Important in Neonates?
Neonates are at a higher risk for bleeding disorders due to their immature coagulation system. Conditions such as hemophilia, Vitamin K deficiency bleeding, and disseminated intravascular coagulation (DIC) can be life-threatening if not managed properly. Recombinant clotting factors provide a reliable and safe option for treatment, reducing the risk of transfusion-related infections and allergic reactions that are often associated with plasma-derived products.
